WORK End Period Cash Flow from 2010 to 2024

WOK Stock   6.00  0.38  5.96%   
WORK Medical End Period Cash Flow yearly trend continues to be quite stable with very little volatility. The value of End Period Cash Flow is projected to decrease to about 958.2 K. From the period between 2010 and 2024, WORK Medical, End Period Cash Flow regression line of its data series had standard deviation of  567,003 and standard deviation of  567,003. View All Fundamentals
 
End Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
1.9 M
Current Value
958.2 K
Quarterly Volatility
567 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check WORK Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WORK Medical's main balance sheet or income statement drivers, such as Tax Provision of 40.2 K, Interest Expense of 359.7 K or Selling General Administrative of 3.1 M, as well as many indicators such as . WORK financial statements analysis is a perfect complement when working with WORK Medical Valuation or Volatility modules.
  
Check out the analysis of WORK Medical Correlation against competitors.

Latest WORK Medical's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of WORK Medical Technology over the last few years. It is WORK Medical's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in WORK Medical's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

WORK End Period Cash Flow Regression Statistics

Arithmetic Mean541,926
Geometric Mean358,585
Coefficient Of Variation104.63
Mean Deviation455,366
Median200,401
Standard Deviation567,003
Sample Variance321.5B
Range1.7M
R-Value0.76
Mean Square Error147.5B
R-Squared0.57
Significance0
Slope96,050
Total Sum of Squares4.5T

WORK End Period Cash Flow History

2024958.2 K
20231.9 M
20221.6 M
2021773.4 K
2020873.1 K

About WORK Medical Financial Statements

WORK Medical investors utilize fundamental indicators, such as End Period Cash Flow, to predict how WORK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow1.9 M958.2 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether WORK Medical Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if WORK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Work Medical Technology Stock. Highlighted below are key reports to facilitate an investment decision about Work Medical Technology Stock:
Check out the analysis of WORK Medical Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of WORK Medical. If investors know WORK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about WORK Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of WORK Medical Technology is measured differently than its book value, which is the value of WORK that is recorded on the company's balance sheet. Investors also form their own opinion of WORK Medical's value that differs from its market value or its book value, called intrinsic value, which is WORK Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WORK Medical's market value can be influenced by many factors that don't directly affect WORK Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WORK Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if WORK Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WORK Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.